Investing.com - J&J reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
J&J announced earnings per share of $1.88 on revenue of $20.75B. Analysts polled by Investing.com forecast EPS of $1.87 on revenue of $20.78B. That was in comparison with EPS of $1.97 on revenue of $20.39B in the same quarter a year earlier.J&J had announced EPS of $2.12 on revenue of $20.73B in the previous quarter.Analysts are expecting EPS of $2.27 and revenue of $20.7B in the upcoming quarter.
J&J share's are up 2.33% for the year to date and is trading at $149.27 , down-from-52-week-high.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings beat by Novocure Ltd on Thursday, October 31, 2019, who reported EPS of $0.02 on revenue of $92.06M, was in comparison to EPS of $-0.04 on revenue of $86.94M.
ABIOMED had beat expectations on Monday, January 13, 2020 with third quarter EPS of $1.09 on revenue of $221.6M, was in comparison with forecast for EPS of $1.07 on revenue of $226.67M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar